| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100136 | Journal of Crohn's and Colitis | 2011 | 7 Pages |
Abstract
In this small randomised placebo-controlled trial no significant clinical benefit of Probio-Tec AB-25 could be demonstrated in comparison with placebo for maintaining remission in patients with left-sided ulcerative colitis. A difference may be achieved in larger studies, but the clinical significance of this would be questionable. This study was registered in ClinicalTrial.gov (NCT00268164).
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Signe Wildt, Inge Nordgaard, Ulla Hansen, Elke Brockmann, Jüri J. Rumessen,